Cardinal Health Inc (CAH)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Cardinal Health Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 1 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 230.00 $ — 90% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 9.7% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 17
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 06/30/2027 | 12.05 | 11.67 – 12.41 | 276,544 | 11.9% | 17 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 2.42 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 1.65 | 10.00 | 55,264 | -3.80 | 0.70 | -400 | -499 |
| 2025: Q1 | 2.10 | 97.10 | 54,878 | 0.00 | 0.90 | 2,917 | 2,791 |
| 2025: Q2 | 1.00 | 3.40 | 60,159 | 0.80 | 0.40 | 1,527 | 1,295 |
| 2025: Q3 | 1.88 | 10.90 | 64,009 | 22.40 | 0.70 | 973 | 865 |
| 2025: Q4 | 1.99 | 20.70 | 65,441 | 18.40 | 0.70 | 686 | 555 |
| 2026: Q1 | 1.69 | -19.50 | 60,940 | 11.00 | 0.70 | 1,823 | 1,677 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 121,546 | 2,459 | 1,427 | 4.32 | 2,971 | 6,554 | 34,122 |
| 2017 | 129,976 | 2,120 | 1,288 | 4.03 | 1,184 | 6,808 | 40,112 |
| 2018 | 136,809 | 126 | 256 | 0.81 | 2,768 | 6,059 | 39,951 |
| 2019 | 145,534 | 2,060 | 1,363 | 4.53 | 2,722 | 6,328 | 40,963 |
| 2020 | 152,922 | -4,098 | -3,693 | -12.60 | 1,960 | 1,789 | 40,766 |
| 2021 | 162,467 | 472 | 611 | 2.08 | 2,429 | 1,791 | 44,453 |
| 2022 | 181,326 | -607 | -938 | -3.36 | 3,122 | -709 | 43,878 |
| 2023 | 204,979 | 752 | 330 | 1.26 | 2,839 | -2,958 | 43,349 |
| 2024 | 226,827 | 1,243 | 852 | 3.45 | 3,762 | -3,213 | 45,121 |
| 2025 | 222,578 | 2,275 | 1,561 | 6.45 | 2,397 | -2,781 | 53,122 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Cardinal Health, Inc. ist ein Unternehmen für Gesundheitsdienste und -produkte in den USA und international.
| CEO Insider Trades (12 Mo.) | selling own stock |
|---|---|
| Employees | 53,084 |
| Headquarters | Dublin, OH |
| Address | 7000 Cardinal Place, 43017 Dublin, United States |
| Phone | 614 757 5000 |
| Website | cardinalhealth.com |
| IPO Date | 31. Dec 1987 |
| ISIN | US14149Y1082 |
| Stock Split | 3:2 on 04/23/2001 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Jason M. Hollar | CEO & Director | 1973 |
| Aaron E. Alt J.D. | Chief Financial Officer | 1972 |
| Jessica L. Mayer | Chief Legal & Compliance Officer | 1969 |
| Stephen M. Mason | Chief Executive Officer of GMPD segment | 1971 |
| Deborah L. Weitzman | Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment | 1965 |
| Mary C. Scherer | Senior VP & Chief Accounting Officer | – |
| Matt Sims | Vice President of Investor Relations | – |
| Valerie Christine Pitteroff | Chief Human Resources Officer | – |
| Craig Cowman | President of Biopharma Solutions & Strategic Sourcing | – |
| Patricia M. English CPA | Senior Vice President | 1980 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.